Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$72.32
neg -0.15
-0.21%
Today's Range: 71.55 - 72.90 | GILD Avg Daily Volume: 9,617,500
Last Update: 12/07/16 - 11:25 AM EST
Volume: 4,566,271
YTD Performance: -28.38%
Open: $71.78
Previous Close: $72.47
52 Week Range: $77.92 - $120.37
Oustanding Shares: 1,317,456,071
Market Cap: 95,331,121,298
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 10 9
Moderate Buy 1 1 1 1
Hold 8 8 9 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.81 1.85 1.95 1.94
Latest Dividend: 0.47
Latest Dividend Yield: 2.60%
Dividend Ex-Date: 12/13/16
Price Earnings Ratio: 6.72
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
6.72 6.10 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.95% -30.36% -2.05%
GROWTH 12 Mo 3 Yr CAGR
Revenue 31.10 2.40 0.49
Net Income 50.10 6.00 0.90
EPS 62.00 6.20 0.92
Earnings for GILD:
EBITDA 23.29B
Revenue 32.64B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $2.52 $2.58 $11.17 $10.46
Number of Analysts 7 2 9 8
High Estimate $2.62 $2.63 $11.33 $11.26
Low Estimate $2.31 $2.52 $10.79 $9.80
Prior Year $3.27 $2.98 $12.45 $11.17
Growth Rate (Year over Year) -22.89% -13.59% -10.32% -6.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Bret Jensen

 | Dec 6, 2016 | 10:00 AM EST
It can take many months or quarters before the market recognizes the value of a downtrodden name.
RMPIA
By

Doug Kass

 | Dec 5, 2016 | 4:50 PM EST
The U.S. dollar has weakened considerably. The price of crude oil was down by about two bits to $51.45. Gold fell by another $4 to $1,174. Ag commodities got a lift: wheat up $0.04, corn up $0.11, soybeans up $0.16, oats down $0.15. Lumber down $2. Bonds, the object of my affection today ("Trade of the Week"), reversed from early morning lows. After yields rose by more than 4 basis points on the 10-year, the close was relatively flat. TLT slipped $1.20 from Friday's close, ending the day slightly higher. Bravo! Municipal bonds sold off. But closed-end muni-bond funds got a lift (e.g., Eaton Vance Municipal Incm 2028 Term (ETX) and Blackrock Taxable Municipal Bond Trust (BBN) ) -- hard to explain why, though! The 2s/10s spread dropped by two basis points to 127 basis points. Banks, stated simply, are continuing to be the "world's fair" -- regardless of what rates do. Short Bank of America (BAC) , Citigroup (C) and JP Morgan Chase (JPM) (all small). Brokerages bullish -- led by Goldman Sachs (GS) (on a late HSBC (HSBC) buy upgrade today, seriously??!!!). But insurance lagged, though my long Hartford Financial (HIG) was modestly higher. Auto stocks stalled. I am still small short General Motors (GM) and Ford (F) . Retail was stronger -- with upside leadership from Nordstrom (JWN)  , Best Buy (BBY)  , Foot Locker (FL)  , Nike (NKE) and Urban Outfitters (URBN) . JC Penney (JCP)
RMPIA
By

Doug Kass

 | Dec 1, 2016 | 5:48 PM EST
The U.S. dollar weakened. The price of crude oil rallied for a second day in a row, rising $1.50 to almost $51. Gold flat, no bounce. Agricultural commodities: Wheat up $0.07, corn down $0.05, soybean unchanged, oats up $0.05. Lumber up $1. Bonds got schmeissed but traded well off the day's lows (as the 10-year yield touched 2.5%). The 10-year and long-bond yields rose by 9 basis points. The 2s/10s spread rose by another 5 basis points to 130 basis points. Muncipals were lower. Junk bonds got hit badly, despite the rise in crude oil. Blackstone / GSO Strategic Credit Fund (BGB)  rose $0.08. Banks were powerful to the upside. I reshorted at reasonably good prices in the afternoon, after covering my small rental shorts in pre-market trading earlier. Insurance stocks flew. Long Hartford Financial (HIG)  , which rose. Brokerages so strong -- Morgan Stanley (MS) and Goldman Sachs (GS) (up $7). Retail was strong led by Target (TGT) , Foot Locker (FL) , Nike (NKE) and JC Penney (JCP) (long). Autos were the "world's fair." I still have tag end short positions. I expect the upside move to get over-done short term, and I will reload on the short side. Energy stocks up, but small relative to the commodity. Old tech was clobbered. International Business Machines (IBM) , Intel (INTC) , Cisco (CSCO) (short and working nicely) and Microsoft (MSFT) got bashed along with the entire sector. Biotech was down 2%. Allergan (AGN) and Gilead Sciences (GILD) were weak. New lows Vertex Pharmaceuticals (VRX) . Spec weak again (Portula Pharmaceuticals (PTLA) , Sage (SAGE) , Intrexon (XON) , FibroGen (FGEN) , ACADIA Pharmaceuticals (ACAD)  . Big pharma hurtin' badly, once more. Merck (MRK) , Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) being liquidated, much like tech. Media mixed message. Disney (DIS) lower. Ag equipment: Deere (DE) up large on an upgrade, though Caterpillar (CAT) still experiencing weak fundies. Consumer staples broadly lower. Campbell Soup (CPB) excelled on a relative basis, though. (T)FANG a source of funds. Tesla (TSLA) , Facebook (FB) , Amazon (AMZN) and Alphabet (GOOGL) a collective mess. In individual stocks: DuPont (DD) , new high. Radian (RDN) up another up 2%. Oaktree Capital (OAK) not so mighty. Apple hit. Here are some value-added contributions on the site today: 1. Jim "El Capitan" Cramer on " Not What Bulls Wanted to See ."  2. "Meet" Brett Jensen on rotation.  3. Tim "Not Judy or Phil" Collins
RMPIA
By

Bret Jensen

 | Dec 1, 2016 | 1:10 PM EST
What's in, what's out and who should thrive in the new political landscape.
RMPIA
By

Doug Kass

 | Nov 30, 2016 | 8:08 AM EST
I try through rigorous analysis to identify sectors and companies with intermediate-term prospects that are deteriorating relative to consensus expectations, isolating those areas and corporations with secular growth prospects that are reduced by a changing business landscape. Examples of stocks that I am short that may fit this description include Disney (DIS) , Coca-Cola (KO) and Apple (AAPL) . But this morning I want to look at current and possible shorts -- a shopping list, so to speak -- by iden
RMPIA

updatePiper Healthcare Conf.

Nov 29, 2016 | 7:31 AM EST
Thomson ONE
Piper Jaffray Healthcare Conference (Day 1 of 2) - 11/29/16 - 11/30/16 New York, NY
RMPIA
By

Doug Kass

 | Nov 28, 2016 | 3:28 PM EST
The U.S. dollar weakened. Crude oil rose by $1.23 to $47.29 on conflicting OPEC reports. Gold climbed by about $12 per ounce to above $1,190 (it had been up $18 earlier). Agricultural commodities were mixed: Wheat down $0.02, corn flat, soybean up $0.12 (continuing its monster run in price) and oats down $0.06. Lumber up $3. Bonds were lower in yield and higher in price. The 10-year yield dropped by five basis points and the long bond by three basis points. The 2s/10s spread declined by three basis points as the yield curve flattened. Municipals flat-lined. Closed-end muni-bond funds recovered a bit. Junk bonds slightly higher. Blackstone/GSO Strategic Credit Fun (BGB) was flat. Banks got clipped. But brokerages were slightly higher. Insurance profit-taking after a big run. Retail was on sale with Nordstrom (JWN) , Home Depot (HD) , Best Buy (BBY) , Target (TGT) and JC Penney (JCP) weak. Autos lower. According to J.D. Power, incentives are at near-record levels. Not good for profits/margins. Biotech down 1.5% (Celgene (CELG) and Gilead Sciences (GILD) off a beaner each), but spec biotech (e.g. Intrexon (XON) , Portola Pharmaceuticals (PTLA)  , SAGE (SAGE)  , Aerie Pharmaceuticals (AERI) ) weak. Big pharma continues to weaken, led by Merck (MRK)  , Bristol-Myers Squibb (BMY)  , Eli Lilly (LLY)
RMPIA
By

Bret Jensen

 | Nov 28, 2016 | 11:00 AM EST
Small-caps could also benefit from abating tax-loss selling.
RMPIA
By

Doug Kass

 | Nov 18, 2016 | 3:25 PM EST
The market is amazingly resistant. The Russell Index is killing the shorts -- up, again. Brokerages (Goldman Sachs (GS) , Morgan Stanley (MS) ) don't quit. Agricultural commodities are ripping higher: wheat up $0.05, corn up $0.04, soybeans up $0.06. The Bad Biotech is down 2%. Allergan (AGN) and Gilead Pharmaceuticals (GILD) are leading downside stocks. Alphabet (
RMPIA
By

Bret Jensen

 | Nov 18, 2016 | 10:00 AM EST
With the election resolved, biotech could be ripe for consolidation.
Market mixed with NASDAQ down a good amount.  Biotech down 3% as it is the "Trump Spe...
We bought some calls yesterday and rolled up.  This chart is fantastic, I'll have tha...
Today I'll be talking credit spreads and specific trading strategies after the close today...
Market slightly up at midday across the major indices.  Oil drifting back down to $50...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.